High-risk Secondary Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for High-risk Secondary Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-28Clinical Trial Update: A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia [Phase 3]
A Phase 3 bridging study evaluating liposomal cytarabine-daunorubicin for older patients with treatment-naive high-risk secondary acute myel…